Urolithin A and mitophagy: does Mitopure actually work?

TL;DR

• Urolithin A is a postbiotic - gut bacteria make it from ellagitannins in pomegranate, berries and walnuts, and only about 12% of people produce meaningful amounts.
• The mechanism is mitophagy activation via the PINK1/Parkin pathway, clearing dysfunctional mitochondria so the cell keeps a healthier population.
• It has the most repeated human RCT evidence of any mitochondrial compound in ordinary ageing adults, which is genuinely rare in this field.
• The headline endpoints were frequently missed - peak power in the four-month middle-aged trial, and six-minute walk and muscle ATP in the 65–90 trial.
• What repeated was endurance and biomarkers - hand and leg muscle endurance, with reduced acylcarnitines and CRP, and good tolerability across trials.
• A 15 July 2026 Massachusetts judgment against 19 sellers found products labelled urolithin A with none detectable or well below label - the trials are evidence about the compound, not about a capsule bearing its name.

Updated September 2026: adds the 15 July 2026 District of Massachusetts judgment against 19 online sellers of products labelled as urolithin A, and what it establishes about the distance between a label claim and the trial evidence. The efficacy assessment is unchanged.

Educational content, not medical advice. Urolithin A is a dietary supplement, not an approved drug. Trial doses are reported as study facts, not instructions. No protocol is given.

---

While most "mitochondrial" compounds are investigational or oversold, urolithin A (sold as Mitopure) stands out for an unusual reason in this space: it has real, repeated human randomized-controlled-trial evidence. It works by triggering mitophagy - your cells' process for recycling worn-out, damaged mitochondria so fresher ones can take over. The honest read: trials in middle-aged and older adults show modest but genuine improvements in muscle endurance, some strength, and mitochondrial biomarkers - while often missing their headline primary endpoints. So it's neither hype nor miracle: it's the best-evidenced of the mito compounds, with effects that are real and measured rather than dramatic. Here's the grounded picture.

What it is and how it works

Urolithin A is a postbiotic - a compound your gut bacteria make from ellagitannins in foods like pomegranate, berries and walnuts. The catch: only about 12% of people naturally produce meaningful amounts (it depends on your microbiome), which is the rationale for taking it directly rather than eating pomegranates and hoping. Its mechanism is mitophagy activation (via the PINK1/Parkin pathway) - clearing out dysfunctional mitochondria so the cell can maintain a healthier population. Since impaired mitophagy is part of why mitochondria decline with age, "recycle the old engines" is a genuinely sensible target.

What the human trials actually show

This is where urolithin A earns its place - and where honesty matters:

The pattern: consistent signals on endurance and biomarkers, mixed on the splashy primary endpoints. Real effect, modest size. And notably safe and well-tolerated across trials.

The honest read

Three things to hold together:

• It's the best-evidenced mito compound for healthy/aging adults. Unlike SS-31 (approved for a rare disease only) or NMN/NR (uncertain tissue effect), urolithin A has repeated RCTs in normal aging adults. That's rare here.
• The effect is modest, not transformative. Strength/endurance gains are measurable but small, and primary endpoints often weren't hit. "Recycles your mitochondria" is true; "renewed energy" oversells it.
• It's a supplement, not a drug - which means quality varies; the trials used a specific branded form, and supplement regulation is lighter than for medicines.

Where it fits

Urolithin A is best thought of as an evidence-backed adjunct - sitting alongside the benchmark that still beats it: exercise also activates mitophagy, and does so as part of a far broader benefit. So the sensible framing is train first, then consider urolithin A as a measured add-on, not as a substitute for the thing that works best. As with everything in this area, measure don't guess - and supplements still warrant a conversation with your physician, especially alongside other interventions.

What a label claim is worth: the July 2026 judgment

There is a gap in this article that the evidence above cannot close on its own, and a court case has now measured it.

On 15 July 2026, the US District Court for the District of Massachusetts entered default judgments and permanent injunctions against 19 online sellers of products marketed as containing urolithin A, in a suit brought by Timeline/Amazentis. The court awarded more than $5.3 million in total, with individual awards ranging from a few hundred dollars to over $2.7 million and several trebled as enhanced damages. The allegation the defaulting sellers did not contest was the material one: independent testing found the products at issue contained no detectable urolithin A at all, or urolithin A at levels materially below what the label represented.

Read this as a statement about evidence, not about shopping. The point is not that some sellers are bad and others are good - that is a question this article is not equipped to answer and does not try to. The point is narrower and more important: every trial result summarised above was generated using a characterised, quantified compound, and none of it transfers to a product that does not contain what its label says. The RCT evidence is evidence about urolithin A. It is not evidence about a capsule sold under that name. When those two come apart, the trial data stops applying, and no amount of published research repairs the gap.

That is the general lesson, and it is the reason we keep repeating that a supplement is not a drug. Supplement regulation does not require pre-market verification of identity or content the way drug approval does. The trials used a specific branded, characterised form; the judgment describes what turned up when someone actually tested a set of products that claimed to be the same thing. Both facts are about product identity, and product identity is upstream of every efficacy question in this article. If you cannot establish what is in the container, the evidence base is not the thing determining your outcome.

The practical route through this is the same one that applies everywhere in this field: verified product, obtained through a clinician or supplier who can document identity and content, rather than a label claim taken on trust.

The bottom line - and where to start

Urolithin A (Mitopure) is the rare mito compound with real human RCT evidence - it activates mitophagy and produces modest, genuine gains in muscle endurance and mitochondrial biomarkers, while often missing its headline endpoints. That makes it neither hype nor hero: a legitimate, evidence-backed adjunct to the foundation (exercise), not a replacement for it. Approached that way - measured, honest about effect size - it's one of the more defensible choices in a hype-heavy field.

Explore it with verified supply. Every Vivre Labs lot is independently tested and the certificate of analysis is published, so you know exactly what is in the vial. Explore SS-31.

Frequently asked questions

Does urolithin A actually work? It has real human RCT evidence - modest improvements in muscle endurance, some strength, and mitochondrial biomarkers - though trials often missed their primary endpoints. Real but modest, and it's the best-evidenced mito compound for healthy adults.

What does urolithin A do? It activates mitophagy - your cells' recycling of damaged mitochondria - which supports mitochondrial health. Only ~12% of people make meaningful amounts naturally, hence supplementation.

Is urolithin A better than exercise? No. Exercise also activates mitophagy and delivers far broader benefits. Urolithin A is best viewed as an evidence-backed adjunct, not a replacement.

Related reading

• Mitochondria and aging: why your cellular engines matter · NAD⁺ vs NMN vs NR · SS-31 vs MOTS-c · Does urolithin A build muscle? · mTOR, autophagy and rapamycin
• Part of The Complete Guide to Mitochondria & Longevity

---

Educational content, not medical advice. Urolithin A is a dietary supplement, not an approved drug; quality varies by product. Trial figures describe study populations. Claims for the Malaysian market are subject to MAB requirements.

References

• Singh A, et al. Urolithin A improves muscle strength and exercise performance in middle-aged adults (RCT). Cell Rep Med. 2022 (NCT03464500). · Liu S, et al. Urolithin A and muscle endurance in older adults (RCT). JAMA Netw Open. 2022;5:e2144279. · Andreux PA, et al. The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial health. Nat Metab. 2019;1:595–603. · Denk D, et al. Urolithin A and immune aging (RCT). Nat Aging. 2026.